JW Pharmaceutical Corporation (001060) Price & Analysis

― Followers

001060 Stock Chart & Stats

$27250.00

-$1,600.00(-5.55%)

Aug 18, 2026

―

Day’s Range― - ―

52-Week Range$20,700.00 - $39,250.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)N/A

Market Cap

₩658.09B

Enterprise Value$603.48K

Total Cash (Recent Filing)₩31.69B

Total Debt (Recent Filing)₩54.12B

Price to Earnings (P/E)6.9

Beta0.40

Next Earnings

Nov 18, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)2958.45

Shares Outstanding23,285,930

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG Ratio-2.42

Price to Book (P/B)1.67

Price to Sales (P/S)0.79

P/FCF Ratio7.27

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

001060 FAQ

What was JW Pharmaceutical Corporation’s price range in the past 12 months?

JW Pharmaceutical Corporation lowest stock price was $20700.00 and its highest was $39250.00 in the past 12 months.

What is JW Pharmaceutical Corporation’s market cap?

JW Pharmaceutical Corporation’s market cap is ₩658.09B.

When is JW Pharmaceutical Corporation’s upcoming earnings report date?

JW Pharmaceutical Corporation’s upcoming earnings report date is Nov 18, 2026 which is in 91 days.

How were JW Pharmaceutical Corporation’s earnings last quarter?

JW Pharmaceutical Corporation released its earnings results on Aug 14, 2026. The company reported $1154.591 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is JW Pharmaceutical Corporation overvalued?

According to Wall Street analysts JW Pharmaceutical Corporation’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does JW Pharmaceutical Corporation pay dividends?

JW Pharmaceutical Corporation pays a N/A dividend of $650 which represents an annual dividend yield of N/A. See more information on JW Pharmaceutical Corporation dividends here

What is JW Pharmaceutical Corporation’s EPS estimate?

JW Pharmaceutical Corporation’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does JW Pharmaceutical Corporation have?

JW Pharmaceutical Corporation has 23,285,930 shares outstanding.

What happened to JW Pharmaceutical Corporation’s price movement after its last earnings report?

JW Pharmaceutical Corporation reported an EPS of $1154.591 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.228%.

Which hedge fund is a major shareholder of JW Pharmaceutical Corporation?

Currently, no hedge funds are holding shares in KR:001060

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

JW Pharmaceutical Corporation

JW Pharmaceutical Corporation, established in 1945 and headquartered in Seoul, South Korea, operates globally, focusing on the development, manufacturing, and distribution of a comprehensive range of pharmaceuticals and medical supplies. Its diverse product portfolio addresses numerous therapeutic areas, including cardiovascular, gastrointestinal, urinary, and metabolic health, as well as infectious diseases, women's health, renal and central nervous system disorders, anti-anemic treatments, respiratory ailments, rheumatic arthritis, oncology, anesthesia, antidotes, and advanced nutritional support.